source
- Biotech firms rush to develop gene-editing cure for rare alpha-1 antitrypsin deficiencyA wave of biotech companies is intensifying efforts to cure alpha-1 antitrypsin deficiency (AATD), a rare liver and lung disorder, using gene-editing approaches. Companies such as Beam, Wave Life…
- Trump administration proposes four-year visa cap for foreign PhD students and postdocs, sparking science community concernsThe Department of Homeland Security announced a new rule that limits the stay of international graduate students and postdoctoral researchers in the United States to four years on nonimmigrant visa…